[Featured Stock] Bridge Biotherapeutics Surges on No-Dilution Announcement
[Asia Economy Reporter Minji Lee] Bridge Biotherapeutics surged sharply following news of its decision to conduct a free capital increase.
At 11:09 AM on the 8th, Bridge Biotherapeutics was trading at 42,450 KRW, up 26.53% from the previous session. On the same day, the company announced that it had decided to allocate 2 new shares for every 1 common share through a free capital increase.
The new shares amount to 12,774,116 common shares, bringing the total number of issued shares to 19,161,174 after the free capital increase.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- "To Get Revenge on Ex-Girlfriend" US McDonald's Manager Spits on French Fries
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
The record date for the new share allocation is the 23rd of this month. The scheduled listing date is the 15th of next month.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
